Nifty
Sensex
:
:
10491.05
34142.15
108.35 (1.04%)
322.65 (0.95%)

Pharmaceuticals & Drugs

Rating :
58/99

BSE: 506690 | NSE: UNICHEMLAB

330.00
-3.95 (-1.18%)
23-Feb-2018 | 3:50PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 331.15
  • 336.95
  • 327.40
  • 333.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 87932
  • 290.18
  • 382.00
  • 231.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,013.20
  • 144.75
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,095.12
  • 0.91%
  • 0.83

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.06%
  • 7.20%
  • 22.76%
  • FII
  • DII
  • Others
  • 0.07%
  • 12.17%
  • 7.74%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Standalone Figures in Rs. Crores

Description
Sep 17
Sep 16
Var%
Jun 17
Jun 16
Var%
Mar 17
Mar 16
Var%
Dec 16
Dec 15
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
-
1,519.50
1,332.65
1,201.79
1,133.45
1,080.80
875.46
824.04
747.39
735.23
671.35
Net Sales Growth
-
14.02%
10.89%
6.03%
4.87%
23.46%
6.24%
10.26%
1.65%
9.52%
 
Cost Of Goods Sold
-
442.72
386.97
378.57
332.84
343.06
278.55
237.98
225.17
244.13
256.57
Gross Profit
-
1,076.78
945.67
823.23
800.61
737.75
596.91
586.07
522.22
491.10
414.77
GP Margin
-
70.86%
70.96%
68.50%
70.63%
68.26%
68.18%
71.12%
69.87%
66.80%
61.78%
Total Expenditure
-
1,340.90
1,168.77
1,100.79
955.75
910.06
759.42
674.08
576.53
593.04
584.99
Power & Fuel Cost
-
46.13
38.25
39.39
35.97
31.36
26.22
22.50
16.23
15.00
14.64
% Of Sales
-
3.04%
2.87%
3.28%
3.17%
2.90%
2.99%
2.73%
2.17%
2.04%
2.18%
Employee Cost
-
300.09
255.92
223.20
187.37
164.88
140.06
123.99
99.31
95.96
91.38
% Of Sales
-
19.75%
19.20%
18.57%
16.53%
15.26%
16.00%
15.05%
13.29%
13.05%
13.61%
Manufacturing Exp.
-
174.59
150.54
145.03
137.05
119.15
101.54
102.67
77.15
78.86
89.25
% Of Sales
-
11.49%
11.30%
12.07%
12.09%
11.02%
11.60%
12.46%
10.32%
10.73%
13.29%
General & Admin Exp.
-
162.94
167.66
153.29
127.77
104.73
88.54
79.74
71.83
71.35
49.91
% Of Sales
-
10.72%
12.58%
12.76%
11.27%
9.69%
10.11%
9.68%
9.61%
9.70%
7.43%
Selling & Distn. Exp.
-
212.35
166.84
157.12
134.03
135.93
116.00
106.52
80.88
80.92
75.60
% Of Sales
-
13.97%
12.52%
13.07%
11.82%
12.58%
13.25%
12.93%
10.82%
11.01%
11.26%
Miscellaneous Exp.
-
2.06
2.58
4.19
0.73
10.97
8.50
0.70
5.96
6.83
75.60
% Of Sales
-
0.14%
0.19%
0.35%
0.06%
1.01%
0.97%
0.08%
0.80%
0.93%
1.14%
EBITDA
-
178.60
163.88
101.00
177.70
170.74
116.04
149.96
170.86
142.19
86.36
EBITDA Margin
-
11.75%
12.30%
8.40%
15.68%
15.80%
13.25%
18.20%
22.86%
19.34%
12.86%
Other Income
-
11.02
19.11
20.72
42.38
16.96
12.50
8.32
7.98
10.13
7.46
Interest
-
3.37
2.90
3.04
3.19
3.29
4.08
2.39
2.38
2.56
2.19
Depreciation
-
45.18
38.79
41.27
45.72
38.34
30.43
29.22
23.21
22.41
18.14
PBT
-
141.07
141.31
77.41
171.17
146.07
94.03
126.66
153.24
127.36
73.48
Tax
-
32.58
29.30
2.13
43.00
32.85
22.77
31.68
30.43
19.20
16.75
Tax Rate
-
23.09%
21.27%
2.75%
25.12%
22.49%
24.22%
25.01%
19.86%
15.08%
24.59%
PAT
-
108.49
108.48
75.28
128.16
113.23
71.26
94.98
122.81
108.16
51.39
PAT before Minority Interest
-
108.49
108.48
75.28
128.16
113.23
71.26
94.98
122.81
108.16
51.39
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
7.14%
8.14%
6.26%
11.31%
10.48%
8.14%
11.53%
16.43%
14.71%
7.65%
PAT Growth
-
0.01%
44.10%
-41.26%
13.19%
58.90%
-24.97%
-22.66%
13.54%
110.47%
 
Unadjusted EPS
-
11.92
11.86
8.31
18.69
12.52
7.89
10.53
34.14
29.97
14.26

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
1,063.62
954.33
867.52
816.61
727.07
660.58
617.70
562.92
484.45
411.52
Share Capital
18.18
18.17
18.15
18.13
18.09
18.06
18.05
18.03
18.03
18.02
Total Reserves
1,044.00
935.01
848.52
797.74
707.98
641.80
598.85
544.19
464.39
392.10
Non-Current Liabilities
64.49
76.02
74.21
97.72
94.31
92.67
87.44
70.46
72.10
56.59
Secured Loans
0.44
22.98
20.35
24.65
20.89
20.47
19.01
15.29
20.95
6.49
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
23.49
22.72
20.48
18.78
17.83
Long Term Provisions
25.33
12.58
8.88
7.64
9.19
10.24
7.90
0.00
0.00
0.00
Current Liabilities
455.81
275.09
211.76
230.32
251.12
233.30
176.15
165.34
146.30
134.84
Trade Payables
218.03
163.95
138.23
150.52
156.63
140.30
109.99
115.14
101.30
90.05
Other Current Liabilities
68.01
60.56
45.86
32.99
36.65
34.28
26.00
14.56
15.77
11.15
Short Term Borrowings
97.62
12.93
1.63
1.04
6.17
25.42
9.04
0.00
0.00
0.00
Short Term Provisions
72.15
37.65
26.05
45.78
51.67
33.30
31.13
35.64
29.23
33.64
Total Liabilities
1,583.92
1,305.44
1,153.49
1,144.65
1,072.50
986.55
881.29
798.72
702.85
602.95
Net Block
491.00
402.60
415.99
419.29
447.76
408.39
377.31
333.35
300.81
238.21
Gross Block
565.36
439.53
724.65
688.25
675.87
599.27
537.04
464.60
414.13
333.01
Accumulated Depreciation
74.35
36.92
308.66
268.96
228.11
190.87
159.73
131.25
113.31
94.80
Non Current Assets
760.03
673.34
589.07
563.97
594.06
547.20
456.50
396.26
376.76
341.48
Capital Work in Progress
249.98
237.13
122.64
90.54
132.20
112.76
62.87
62.88
75.93
103.19
Non Current Investment
5.72
5.54
5.83
5.72
5.72
0.03
0.03
0.03
0.02
0.08
Long Term Loans & Adv.
13.33
28.05
44.61
48.42
8.38
26.02
16.29
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
823.89
632.11
564.42
580.68
478.44
439.35
424.79
402.46
326.08
261.46
Current Investments
8.00
8.04
35.04
5.67
33.06
14.50
21.29
59.18
1.00
0.00
Inventories
281.71
230.57
207.68
203.49
143.05
157.96
150.26
107.54
103.39
83.28
Sundry Debtors
320.49
220.09
191.58
196.51
206.95
183.25
185.13
166.97
151.59
139.93
Cash & Bank
16.14
20.13
26.96
52.15
24.64
23.23
15.16
23.64
34.37
10.05
Other Current Assets
197.55
30.51
20.92
17.19
70.75
60.40
52.95
45.13
35.73
28.20
Short Term Loans & Adv.
170.98
122.77
82.25
105.67
61.73
53.14
47.14
45.13
35.73
28.20
Net Current Assets
368.08
357.02
352.66
350.36
227.32
206.05
248.65
237.12
179.78
126.62
Total Assets
1,583.92
1,305.45
1,153.49
1,144.65
1,072.50
986.55
881.29
798.72
702.84
602.94

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Cash From Operating Activity
111.91
78.10
86.73
171.23
124.08
68.59
129.10
102.77
70.03
46.79
PBT
137.68
77.41
171.17
146.07
94.03
126.66
153.24
127.36
68.13
88.09
Adjustment
39.65
35.57
18.74
47.15
39.37
27.54
25.31
25.49
24.23
12.79
Changes in Working Capital
-34.16
-16.49
-66.32
13.05
13.51
-54.81
-21.95
-29.70
-11.21
-42.22
Cash after chg. in Working capital
143.16
96.49
123.58
206.27
146.91
99.39
156.60
123.14
81.15
58.66
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-31.25
-18.39
-36.85
-35.04
-22.83
-30.81
-27.50
-20.37
-11.12
-11.87
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-85.33
-52.34
35.70
-118.45
-101.80
-47.60
-100.15
-57.94
-82.25
-60.72
Net Fixed Assets
154.89
-73.58
38.14
-92.98
-106.47
-67.03
-39.23
-45.49
-80.05
-81.78
Net Investments
42.09
-32.73
20.34
-34.14
-5.98
28.17
-67.50
-19.00
-5.19
-9.13
Others
-282.31
53.97
-22.78
8.67
10.65
-8.74
6.58
6.55
2.99
30.19
Cash from Financing Activity
-33.42
-50.95
-94.92
-51.38
-14.21
-29.46
-39.68
-20.52
-4.91
-45.31
Net Cash Inflow / Outflow
-6.84
-25.19
27.51
1.41
8.07
-8.48
-10.73
24.31
-17.13
-59.24
Opening Cash & Equivalents
26.96
52.15
24.64
23.23
15.16
23.64
34.37
10.05
27.19
86.43
Closing Cash & Equivalent
20.13
26.96
52.15
24.64
23.23
15.16
23.64
34.36
10.05
27.19

Financial Ratios

Consolidated /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
116.88
104.93
95.48
90.02
80.27
73.06
68.36
62.36
53.52
45.52
ROA
7.51%
8.82%
6.55%
11.56%
11.00%
7.63%
11.31%
16.36%
16.57%
8.84%
ROE
10.77%
11.92%
8.95%
16.62%
16.34%
11.16%
16.11%
23.51%
24.24%
13.01%
ROCE
13.42%
14.97%
9.29%
21.84%
20.13%
14.03%
20.37%
27.72%
27.06%
16.68%
Fixed Asset Turnover
3.06
2.32
1.71
1.67
1.71
1.55
1.66
1.71
1.99
2.20
Receivable days
64.25
55.72
58.55
64.53
65.42
76.34
77.46
77.49
71.68
75.09
Inventory Days
60.89
59.32
62.03
55.42
50.47
63.88
56.72
51.31
45.90
44.74
Payable days
56.76
52.00
52.61
62.52
65.77
65.64
63.82
75.73
62.75
61.87
Cash Conversion Cycle
68.38
63.05
67.97
57.43
50.11
74.58
70.36
53.06
54.83
57.97
Total Debt/Equity
0.09
0.04
0.03
0.03
0.04
0.11
0.08
0.06
0.08
0.06
Interest Cover
42.87
48.57
26.45
54.66
45.40
24.06
53.94
65.29
50.85
32.04

News Update:


  • Unichem Laboratories gets nod for share buyback
    9th Jan 2018, 09:40 AM

    The buyback would be on proportionate basis through the tender offer route and the company will announce the record date later

    Read More
  • Unichem Lab - Quarterly Results
    8th Jan 2018, 15:06 PM

    Read More
  • Unichem concludes sale, transfer of domestic formulations business in India and Nepal
    14th Dec 2017, 16:14 PM

    This transaction was in pursuance of the definitive binding agreement entered into between Unichem and Torrent on November 3, 2017

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.